Home > Financial Ratios > MANKIND PHARMA

MANKIND PHARMA
Working Capital/Sales

    Back to All Ratios
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Working Capital/Sales(x) 9.592.403.704.532.56

What is the latest Working Capital/Sales ratio of MANKIND PHARMA ?

The latest Working Capital/Sales ratio of MANKIND PHARMA is 9.59 based on Mar2025 Consolidated results.
Year Working Capital/Sales
Mar20259.59
Mar20242.40
Mar20233.70
Mar20224.53
Mar20212.56

How is Working Capital/Sales of MANKIND PHARMA Trending?

Years Working Capital/Sales % Change
Mar2025 9.59
299.58
Mar2024 2.4
-35.14
Mar2023 3.7
-18.32
Mar2022 4.53
76.95
Mar2021 2.56 -

Other Financial Ratios of MANKIND PHARMA


Compare Working Capital/Sales ratio of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹90,805.7 Cr 0.3% 2.4% -22.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹415,073.0 Cr -0% -3.2% -5% Stock Analytics
DIVIS LABORATORIES ₹175,657.0 Cr 4% 5.2% 11.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹134,121.0 Cr 2.4% 4.5% 18.3% Stock Analytics
CIPLA ₹118,431.0 Cr -3.5% -1.5% -2.5% Stock Analytics
DR REDDYS LABORATORIES ₹100,944.0 Cr -3.2% -3.3% -10.6% Stock Analytics


MANKIND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

0.3%

2.4%

-22.7%

SENSEX

-2.6%

-1.3%

7.2%


You may also like the below Video Courses